Antiviral Therapy Plus Either Peripheral Stem Cell or Umbilical Cord Blood Transplantation in Treating Patients Who Are HIV Positive and Have Hematologic Cancer [clinicaltrials:NCT00003435]
Antiviral Therapy Plus Either Peripheral Stem Cell or Umbilical Cord Blood Transplantation in Treating Patients Who Are HIV Positive and Have Hematologic Cancer [clinicaltrials:NCT00003435]
Bio2RDF identifier
NCT00003435
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00003435
identifiers.org URI
actual enrollment [clinicaltrials_vocabulary:actual-enrollment]
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
RATIONALE: Antiviral ag ...... recurrent hematologic cancer.
brief title [clinicaltrials_vocabulary:brief-title]
Antiviral Therapy Plus Either ...... ve and Have Hematologic Cancer
collaborator [clinicaltrials_vocabulary:collaborator]
condition [clinicaltrials_vocabulary:condition]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
OBJECTIVES: I. Determin ...... for this study over 2 years.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
1999-11-01T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
keyword [clinicaltrials_vocabulary:keyword]
AIDS-related peripheral/systemic lymphoma
HIV-associated Hodgkin lymphoma
recurrent adult acute lymphoblastic leukemia
secondary acute myeloid leukemia
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2013-03-06T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00003435
official title [clinicaltrials_vocabulary:official-title]
A Pilot Study Involving Admini ...... n and Hematologic Malignancies
org study id [clinicaltrials_vocabulary:org-study-id]
CDR0000066461
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
secondary id [clinicaltrials_vocabulary:secondary-id]
DUMC-97028
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
1998-05-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2000-12-01T00:00:00Z
identifier
clinicaltrials:NCT00003435
title
Antiviral Therapy Plus Either ...... ve and Have Hematologic Cancer
@en
type
label
Antiviral Therapy Plus Either ...... r [clinicaltrials:NCT00003435]
@en